Kylie E. C. Ainslie

15.8k total citations · 1 hit paper
35 papers, 950 citations indexed

About

Kylie E. C. Ainslie is a scholar working on Infectious Diseases, Modeling and Simulation and Epidemiology. According to data from OpenAlex, Kylie E. C. Ainslie has authored 35 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 19 papers in Modeling and Simulation and 13 papers in Epidemiology. Recurrent topics in Kylie E. C. Ainslie's work include COVID-19 epidemiological studies (19 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and Influenza Virus Research Studies (11 papers). Kylie E. C. Ainslie is often cited by papers focused on COVID-19 epidemiological studies (19 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and Influenza Virus Research Studies (11 papers). Kylie E. C. Ainslie collaborates with scholars based in United Kingdom, Netherlands and United States. Kylie E. C. Ainslie's co-authors include Michael Haber, Christl A. Donnelly, Steven Riley, Helen Ward, William Barclay, Graham Cooke, Deborah Ashby, Christina Atchison, Paul Elliott and Ara Darzi and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Communications.

In The Last Decade

Kylie E. C. Ainslie

34 papers receiving 928 citations

Hit Papers

Estimating the effects of non-pharmaceutical intervention... 2020 2026 2022 2024 2020 100 200 300

Peers

Kylie E. C. Ainslie
Kylie E. C. Ainslie
Citations per year, relative to Kylie E. C. Ainslie Kylie E. C. Ainslie (= 1×) peers Valentina Marziano

Countries citing papers authored by Kylie E. C. Ainslie

Since Specialization
Citations

This map shows the geographic impact of Kylie E. C. Ainslie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kylie E. C. Ainslie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kylie E. C. Ainslie more than expected).

Fields of papers citing papers by Kylie E. C. Ainslie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kylie E. C. Ainslie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kylie E. C. Ainslie. The network helps show where Kylie E. C. Ainslie may publish in the future.

Co-authorship network of co-authors of Kylie E. C. Ainslie

This figure shows the co-authorship network connecting the top 25 collaborators of Kylie E. C. Ainslie. A scholar is included among the top collaborators of Kylie E. C. Ainslie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kylie E. C. Ainslie. Kylie E. C. Ainslie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ainslie, Kylie E. C., Mariëtte Hooiveld, & Jacco Wallinga. (2025). Estimation of the epidemiological characteristics of scabies. Nature Communications. 16(1). 10524–10524.
2.
Peng, Liping, et al.. (2025). Evaluating the association between COVID-19 transmission and mobility in omicron outbreaks in China. Communications Medicine. 5(1). 188–188. 1 indexed citations
3.
Tsang, Tim K., Sheena G. Sullivan, Can Wang, et al.. (2024). Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: a systematic review and meta-analysis. American Journal of Epidemiology. 193(12). 1868–1881. 4 indexed citations
4.
Tsang, Tim K., Sheena G. Sullivan, Yu Meng, et al.. (2024). Evaluating the impact of extended dosing intervals on mRNA COVID-19 vaccine effectiveness in adolescents. BMC Medicine. 22(1). 384–384. 1 indexed citations
6.
Chen, Dongxuan, Benjamin J. Cowling, Kylie E. C. Ainslie, et al.. (2024). Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong. Vaccine. 42(9). 2385–2393. 2 indexed citations
7.
Zachreson, Cameron, Julian Savulescu, Freya M. Shearer, et al.. (2024). Ethical frameworks should be applied to computational modelling of infectious disease interventions. PLoS Computational Biology. 20(3). e1011933–e1011933. 3 indexed citations
8.
Sullivan, Sheena G., Arseniy Khvorov, Can Wang, et al.. (2023). The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness. npj Vaccines. 8(1). 118–118. 9 indexed citations
9.
Ewijk, Catharina E van, et al.. (2023). Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May–July 2022. Vaccine. 41(47). 6952–6959. 6 indexed citations
10.
Ainslie, Kylie E. C., Jantien A. Backer, Pieter T. de Boer, et al.. (2022). A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021. Eurosurveillance. 27(44). 8 indexed citations
11.
Eales, Oliver, Kylie E. C. Ainslie, Caroline E. Walters, et al.. (2022). Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number. Epidemics. 40. 100604–100604. 17 indexed citations
12.
Eales, Oliver, Haowei Wang, David Haw, et al.. (2022). Trends in SARS-CoV-2 infection prevalence during England’s roadmap out of lockdown, January to July 2021. PLoS Computational Biology. 18(11). e1010724–e1010724. 14 indexed citations
13.
Ainslie, Kylie E. C. & Steven Riley. (2022). Is annual vaccination best? A modelling study of influenza vaccination strategies in children. Vaccine. 40(21). 2940–2948. 4 indexed citations
14.
Miura, Fuminari, et al.. (2021). Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization. PLoS Computational Biology. 17(12). e1009697–e1009697. 18 indexed citations
15.
Ward, Helen, Christina Atchison, Matthew Whitaker, et al.. (2021). SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Nature Communications. 12(1). 905–905. 110 indexed citations
16.
Riley, Steven, Oliver Eales, Haowei Wang, et al.. (2020). REACT-1 round 7 interim report: fall in prevalence of swab-positivity in England during national lockdown. medRxiv. 2 indexed citations
17.
Ward, Helen, Christina Atchison, Matthew Whitaker, et al.. (2020). Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. medRxiv. 65 indexed citations
18.
Hay, James A., Amanda Minter, Kylie E. C. Ainslie, et al.. (2020). An open source tool to infer epidemiological and immunological dynamics from serological data: serosolver. PLoS Computational Biology. 16(5). e1007840–e1007840. 16 indexed citations
19.
Shi, Meng, Qian An, Kylie E. C. Ainslie, Michael Haber, & Walter A. Orenstein. (2017). A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination. BMC Infectious Diseases. 17(1). 757–757. 25 indexed citations
20.
Kowalski, Jeanne, Bhakti Dwivedi, Scott Newman, et al.. (2016). Gene integrated set profile analysis: a context-based approach for inferring biological endpoints. Nucleic Acids Research. 44(7). e69–e69. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026